Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment
Johns Hopkins Medicine via YouTube
Gain a Splash of New Skills - Coursera+ Annual Nearly 45% Off
The Perfect Gift: Any Class, Never Expires
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join a seminar from the Joint NIMH Center Series featuring Dr. Reina Bendayan from the University of Toronto as she explores groundbreaking research on molecular therapeutic targets for HIV-Associated Neurocognitive Impairment. Discover the latest findings in neuroHIV research and potential treatment approaches during this hour-long presentation from Johns Hopkins Medicine. Learn about innovative pharmaceutical developments and therapeutic strategies aimed at addressing cognitive impairments in HIV patients. Gain insights from Dr. Bendayan's expertise as a distinguished pharmacologist and fellow of multiple prestigious academic societies (FAAPS, FCSPS, FCAHS) while exploring the intersection of HIV treatment and neurocognitive health.
Syllabus
Uncovering a Novel Molecular Therapeutic Target for HIV-Associated Neurocognitive Impairment
Taught by
Johns Hopkins Medicine